0001973901-24-000001.txt : 20240509 0001973901-24-000001.hdr.sgml : 20240509 20240509134457 ACCESSION NUMBER: 0001973901-24-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240509 DATE AS OF CHANGE: 20240509 EFFECTIVENESS DATE: 20240509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OverT Bio, Inc. CENTRAL INDEX KEY: 0001973901 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-480712 FILM NUMBER: 24929743 BUSINESS ADDRESS: STREET 1: 430 E 29TH ST 14FL CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 6463897709 MAIL ADDRESS: STREET 1: 430 E 29TH ST 14FL CITY: NEW YORK STATE: NY ZIP: 10016 D/A 1 primary_doc.xml X0708 D/A LIVE 0001973901 OverT Bio, Inc. 430 E 29TH ST 14FL NEW YORK NY NEW YORK 10016 6463897709 DELAWARE None None Corporation true 2022 Mateusz Legut 430 E 29th ST 14 FL New York NY NEW YORK 10016 Executive Officer Director Neville Sanjana 430 E 29th ST 14 FL New York NY NEW YORK 10016 Director Vasudev Bailey 430 E 29th ST 14 FL New York NY NEW YORK 10016 Director Sara Choi 430 E 29th ST 14 FL New York NY NEW YORK 10016 Director Biotechnology Decline to Disclose 06b true 0001973901-23-000001 2023-04-04 false true false 0 17014920 15989924 1024996 false 15 0 0 0 false OverT Bio, Inc. /s/Mateusz Legut Mateusz Legut Chief Executive Officer 2024-05-09